{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T21:18:58Z","timestamp":1789852738131,"version":"4.0.1"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Immunology and Immunopathology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.vetimm.2016.03.006","type":"journal-article","created":{"date-parts":[[2016,3,5]],"date-time":"2016-03-05T14:29:30Z","timestamp":1457188170000},"page":"64-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Low-dose oral interferon modulates expression of inflammatory and autoimmune genes in cattle"],"prefix":"10.1016","volume":"172","author":[{"given":"Stephen W.","family":"Mamber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Lins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volkan","family":"Gurel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Hutcheson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Pinedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bechtol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Krakowka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Fields-Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Cummins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vetimm.2016.03.006_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9975(03)00041-0","article-title":"The pathogenesis and diagnosis of foot-and-mouth disease","volume":"129","author":"Alexandersen","year":"2003","journal-title":"J. Comp. Pathol."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0010","series-title":"Somministrazione orale di alfa interferone nel suinetto per il controllo delle sindromi PRSS e PMWS","first-page":"2","author":"Amadori","year":"2002"},{"key":"10.1016\/j.vetimm.2016.03.006_bib0015","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1089\/jir.1997.17.625","article-title":"Low-dose Type I interferons reduce early virus replication of murine cytomegalovirus in vivo","volume":"17","author":"Beilharz","year":"1997","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/jir.2010.0129","article-title":"Interferon-stimulated genes and their protein products: what and how?","volume":"31","author":"Borden","year":"2011","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0025","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1089\/jir.1986.6.305","article-title":"High-affinity receptors for human interferon in bovine lung and human placenta","volume":"6","author":"Branca","year":"1986","journal-title":"J. Interferon Res."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0030","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1006\/cyto.1998.0450","article-title":"Ingested interferon alpha induces Mx RNA","volume":"11","author":"Brod","year":"1999","journal-title":"Cytokine"},{"key":"10.1016\/j.vetimm.2016.03.006_bib0035","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.antiviral.2012.11.009","article-title":"Poly(I:C) combined with multi-epitope protein vaccine completely protects against foot-and-mouth disease virus challenge in pigs","volume":"97","author":"Cao","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0040","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0026-895X(25)11361-8","article-title":"Porcine leukocyte interferon and antiviral activity in human cells","volume":"15","author":"Carter","year":"1979","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0045","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0163-7258(79)90031-7","article-title":"Mechanisms of cross-species activity of mammalian interferons","volume":"7","author":"Carter","year":"1979","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0050","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3109\/08923979009006475","article-title":"Receptors for human interferon \u03b1 on bovine cells: specificity and tissue distribution","volume":"12","author":"Chambers","year":"1990","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0055","doi-asserted-by":"crossref","first-page":"9891","DOI":"10.1128\/JVI.73.12.9891-9898.1999","article-title":"Ability of foot-and-mouth disease virus to form plaques in cell culture is associated with suppression of alpha\/beta interferon","volume":"73","author":"Chinsangaram","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0060","doi-asserted-by":"crossref","first-page":"5498","DOI":"10.1128\/JVI.75.12.5498-5503.2001","article-title":"Inhibition of L-depleted foot-and-mouth disease virus replication by alpha\/beta interferon involved double stranded RNA-dependent protein kinase","volume":"75","author":"Chinsangaram","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0065","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1128\/JVI.77.2.1621-1625.2003","article-title":"Novel viral disease control strategy: adenovirus expressing alpha interferon rapidly protects swine from foot-and-mouth disease","volume":"77","author":"Chinsangaram","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0070","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1002\/eji.201242977","article-title":"Type I T interferon potentiates T-cell receptor mediated induction of IL-10-producing CD4 cells","volume":"43","author":"Corre","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0075","first-page":"57","article-title":"A review articleA review article. Interferon administration by the oral route","volume":"18","author":"Cummins","year":"1991","journal-title":"Clin. Microbiol."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0080","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1089\/107999099313442","article-title":"Natural human interferon-\u03b1 administered orally as a treatment of bovine respiratory disease complex","volume":"19","author":"Cummins","year":"1999","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0085","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1089\/107999099313352","article-title":"Oral use of interferon","volume":"19","author":"Cummins","year":"1999","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0090","first-page":"513","article-title":"Oral use of human alpha interferon in cats","volume":"7","author":"Cummins","year":"1988","journal-title":"J. Biol. Response Modif."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0095","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0165-2427(94)05351-R","article-title":"Oral treatment of transmissible gastroenteritis with natural human interferon alpha: a field study","volume":"45","author":"Cummins","year":"1995","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0100","first-page":"193","article-title":"Oral therapy with human interferon alpha in calves experimentally injected with infectious bovine rhinotracheitis virus","volume":"41","author":"Cummins","year":"1993","journal-title":"Arch. lmmunol. Ther. Exp."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0105","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2460\/ajvr.2005.66.164","article-title":"Systemic effects of interferons after oral administration in animals and humans","volume":"66","author":"Cummins","year":"2005","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0110","first-page":"117","article-title":"Interferon inducers and foot-and-mouth disease vaccines: influence of two synthetic polynucleotides on antibody response and immunity in guinea pigs and swine","volume":"41","author":"Cunliffe","year":"1977","journal-title":"Can. J. Comp. Med."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0115","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0042-6822(76)90286-5","article-title":"Molecular modification of interferon: attainment of human interferon in a conformation active on cat cells but inactive on human cells","volume":"70","author":"Desmyter","year":"1976","journal-title":"Virology"},{"key":"10.1016\/j.vetimm.2016.03.006_bib0120","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1089\/jir.2010.0055","article-title":"Porcine Type I interferon rapidly protects swine against challenge with multiple serotypes of foot-and-mouth disease virus","volume":"31","author":"Dias","year":"2011","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0125","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1089\/jir.2012.0012","article-title":"Novel antiviral therapeutics to control foot-and-mouth diseases","volume":"32","author":"Dias","year":"2012","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0130","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1128\/JVI.01874-09","article-title":"Interferon-induced protection against foot-and-mouth disease virus infection correlates with enhanced tissue-specific innate immune cell infiltration and interferon-stimulated gene expression","volume":"84","author":"Diaz-San Segundo","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0135","doi-asserted-by":"crossref","first-page":"5447","DOI":"10.1128\/JVI.03462-12","article-title":"Venezuelan Equine Encephalitis replicon particles can induce rapid protection against foot-and-mouth disease virus","volume":"87","author":"Diaz-San Segundo","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0140","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.virol.2014.08.012","article-title":"Poly ICLC increases the potency of a replication-defective human adenovirus vectored foot-and-mouth disease vaccine","volume":"468\u2013470","author":"Diaz-San Segundo","year":"2014","journal-title":"Virology"},{"issue":"Suppl. 1","key":"10.1016\/j.vetimm.2016.03.006_bib0145","first-page":"S65","article-title":"Protein related to the tocsins","volume":"21","author":"Dron","year":"2001","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0150","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1089\/107999099314306","article-title":"Oral interferon therapy: pharmacokinetics and pharmacodynamics","volume":"19","author":"Eid","year":"1999","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0155","series-title":"Manual of Clinical Immunology","first-page":"120","article-title":"Assay of human immune interferon from lymphocyte-macrophage cultures by a virus plaque reduction method","author":"Epstein","year":"1976"},{"key":"10.1016\/j.vetimm.2016.03.006_bib0160","series-title":"Veterinary Virology","first-page":"421","article-title":"Picornaviridae","author":"Fenner","year":"1987"},{"key":"10.1016\/j.vetimm.2016.03.006_bib0165","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3181\/00379727-197-43277","article-title":"Modulation of peripheral leukocyte counts in mice by oral administration of interferons","volume":"197","author":"Fleischmann","year":"1991","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0170","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3181\/00379727-201-43499","article-title":"Orally administered interferons exert their white blood cell suppression effects via a novel mechanism","volume":"201","author":"Fleischmann","year":"1992","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0175","first-page":"209","article-title":"The use of interferon modulates the negative effects of heat stress on poultry production","volume":"41","author":"Fulton","year":"1993","journal-title":"Arch. Immunol. Ther. Exp. (Warsz)"},{"key":"10.1016\/j.vetimm.2016.03.006_bib0180","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF01877206","article-title":"Oral applications of cytokines","volume":"8","author":"Georgiades","year":"1996","journal-title":"Biotherapy"},{"key":"10.1016\/j.vetimm.2016.03.006_bib0185","first-page":"205","article-title":"Effect of low dose natural human interferon alpha given into the oral cavity on the recovery time and death loss in feedlot hospital pen cattle: a field study","volume":"41","author":"Georgiades","year":"1993","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0190","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/251543a0","article-title":"Pronounced antiviral activity of human interferon on bovine and porcine cells","volume":"251","author":"Gressor","year":"1974","journal-title":"Nature"},{"key":"10.1016\/j.vetimm.2016.03.006_bib0195","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1128\/CMR.17.2.465-493.2004","article-title":"Foot-and-mouth disease","volume":"17","author":"Grubman","year":"2004","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0200","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang","year":"2009","journal-title":"Nature Protoc."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/nar\/gkn923","article-title":"Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists","volume":"37","author":"Huang","year":"2009","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.vetimm.2016.03.006_bib0210","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/nar\/gni054","article-title":"Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces","volume":"33","author":"Imbeaud","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0215","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1089\/107999001300177475","article-title":"Cellular responses in chickens treated with IFN-alpha orally or inoculated with recombinant Marek's disease virus expressing IFN-alpha","volume":"21","author":"Jarosinski","year":"2001","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0220","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1093\/bioinformatics\/bts251","article-title":"DAVID-WS: a stateful web service to facilitate gene\/protein list analysis","volume":"28","author":"Jiao","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.vetimm.2016.03.006_bib0225","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0006-291X(80)90275-2","article-title":"Oligo (2\u20325\u2032) adenylate synthetase in human lymphoblastoid cells","volume":"97","author":"Johnson","year":"1980","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0230","first-page":"223","article-title":"Th1\/Th2 balance: the hypothesis, its limitations, and implications for health and disease","volume":"8","author":"Kidd","year":"2003","journal-title":"Altern. Med. Rev."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0235","doi-asserted-by":"crossref","first-page":"5530","DOI":"10.4049\/jimmunol.166.9.5530","article-title":"IFN-alpha and IL-10 induce the differentiation of human type 1T regulatory cells","volume":"166","author":"Levings","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0240","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.vetmic.2013.04.028","article-title":"Engagement of soluble resistance calcium binding protein (sorcin) with foot-and-mouth disease virus (FMDV) VP1 inhibits Type I interferon response in cells","volume":"166","author":"Li","year":"2013","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0245","first-page":"362","article-title":"Observation of cattle: goats and pigs after administration of synthetic interferon inducers and subsequent exposure to foot and mouth disease virus","volume":"37","author":"McVicar","year":"1973","journal-title":"Can. J. Comp. Med."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0250","first-page":"254","article-title":"The influence of infectious bovine rhinotracheitis virus in the foot-and-mouth disease carrier state","author":"McVicar","year":"1974","journal-title":"Proc. 80th Ann. Meeting US Animal Health Assoc."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0255","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1099\/0022-1317-67-8-1633","article-title":"Biological activities and receptor binding of two human recombinant interferon and their hybrids","volume":"67","author":"Meister","year":"1986","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0260","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0165-2427(95)05480-4","article-title":"Changes in airway inflammatory cell populations in standardbred racehorses after interferon-alpha administration","volume":"49","author":"Moore","year":"1996","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0265","first-page":"594","article-title":"Treatment of inflammatory airway disease in young standardbreds with interferon alpha","volume":"45","author":"Moore","year":"2004","journal-title":"Can. Vet. J."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0270","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0264-410X(03)00560-7","article-title":"Immediate protection of swine from foot-and-mouth disease: a combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease virus subunit vaccine","volume":"22","author":"Moraes","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vetimm.2016.03.006_bib0275","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1128\/JVI.02775-06","article-title":"Enhanced antiviral activity against foot-and-mouth disease virus by using a combination of Type I and II porcine interferons","volume":"81","author":"Moraes","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0280","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1089\/jir.2006.26.675","article-title":"Evidence for the immunostimulatory effect of low-dose orally delivered human IFN-\u03b1 in cattle","volume":"26","author":"Namangala","year":"2006","journal-title":"J. Interferon Cytokine Res ."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0285","unstructured":"OIE, 2015. Office International Des Epizooties, www.oie.int."},{"issue":"8","key":"10.1016\/j.vetimm.2016.03.006_bib0290","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1128\/JVI.06683-11","article-title":"Bovine type III interferon significantly delays and reduces the severity of foot-and-mouth disease in cattle","volume":"86","author":"Perez-Martin","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0295","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1146\/annurev.immunol.22.012703.104622","article-title":"Interleukin-10 and related cytokines and receptors","volume":"22","author":"Pestka","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0300","unstructured":"Pestka, S., 1997. The human interferon-\u03b1 species and hybrid proteins, Semin. Oncol. 24 (3 Suppl. 9) S9-4-S9-17."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0305","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1023\/A:1006694627907","article-title":"Relationship between interferon-gamma, interleukin-10, and interleukin-12 production in chronic hepatitis C and in vitro effects of interferon-alpha","volume":"20","author":"Piazzolla","year":"2000","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0310","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/BF01250512","article-title":"Foot-and-mouth disease virus: protection induced in mice by two orally administered interferon inducers","volume":"42","author":"Richmond","year":"1973","journal-title":"Arch. Ges. Virusforsch."},{"issue":"1","key":"10.1016\/j.vetimm.2016.03.006_bib0315","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1073\/pnas.64.1.81","article-title":"Foot-and-mouth disease virus inhibition induced in mice by synthetic double stranded RNA (polyriboinosinic and polyribocytidylic acids)","volume":"64","author":"Richmond","year":"1969","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0320","first-page":"619","article-title":"Interferon production with strain SF-4 in bovine species","volume":"28","author":"Rosenquist","year":"1967","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0325","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1089\/107999099313415","article-title":"Suppression of late asthmatic response by low-dose oral administration of interferon-\u03b2 in the guinea pig model of asthma","volume":"19","author":"Satoh Y. l. Kasama","year":"1999","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0330","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1089\/107999099313497","article-title":"Treatment of primary Sjogren\u2019s syndrome with low-dose natural human interferon-\u03b1 administered by the oral mucosal route: a phase II clinical trial","volume":"19","author":"Ship","year":"1999","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0335","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1089\/107999099313460","article-title":"Oral use of interferon-\u03b1 stimulates ISG-15 transcription and production by human buccal epithelial cells","volume":"19","author":"Smith","year":"1999","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0340","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1177\/1040638713501675","article-title":"Emergence of porcine epidemic diarrhea virus in the United States: clinical signs, lesions, and viral genomic sequences","volume":"25","author":"Stevenson","year":"2013","journal-title":"Vet. Diagn. Invest."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0345","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1439-0450.1976.tb01627.x","article-title":"Lokale interferonbildung beim rind nach intranasaler infektion mit avirulentem IBR\/IPV-virus und deren wirkung auf eine anschlieffende infektion mit maul-und klausenseuche-virus","volume":"23","author":"Straub","year":"1976","journal-title":"Zbl. Vet. Med."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0350","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1089\/107999099313398","article-title":"Oral use of interferon-\u03b1 delays the onset of insulin-dependent diabetes mellitus in nonobese diabetes mice","volume":"19","author":"Tanaka-Kataoka","year":"1999","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0355","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.autrev.2014.12.009","article-title":"IFN-\u03b1 induces IL-10 production and tilt the balance between Th1 and Th17 in Beh\u00e7et disease","volume":"14","author":"Touzot","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0360","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1089\/107999099314298","article-title":"Oromucosal interferon therapy: marked antiviral and antitumor activity","volume":"19","author":"Tovey","year":"1999","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0365","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1099\/0022-1317-36-2-341","article-title":"Antiviral activity of bovine interferons on primate cells","volume":"36","author":"Tovey","year":"1977","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0370","article-title":"Oral interferon therapy: mechanisms of action","volume":"11","author":"Tovey","year":"2000","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0375","series-title":"Presentation at Annual Meeting ISICR","article-title":"Oromucosal interferon therapy: mechanism(s) of action","author":"Tovey","year":"2003"},{"key":"10.1016\/j.vetimm.2016.03.006_bib0380","unstructured":"United States Department of Agriculture, 2013. FAD Prep Ready Reference Guide: Overview of FAD Vaccine Issues Version 3.0: G1-G2."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0385","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.vetimm.2009.04.005","article-title":"Immunostimulatory effects of natural human interferon-alpha (huIFN-\u03b1) on carps Cyprinus carpio L","volume":"131","author":"Watanuki","year":"2009","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.vetimm.2016.03.006_bib0390","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1089\/107999003322226014","article-title":"Adenovirus-mediated Type 1 interferon expression delays and reduces disease signs in cattle challenged with foot-and-mouth disease virus","volume":"23","author":"Wu","year":"2003","journal-title":"J. Interferon Cytokine Res."},{"issue":"7 Suppl. 2","key":"10.1016\/j.vetimm.2016.03.006_bib0395","first-page":"SS31","article-title":"The history of interferon and its use in animal therapy","volume":"67","author":"Young","year":"1990","journal-title":"East Afr. Med. J."},{"issue":"Pt 2","key":"10.1016\/j.vetimm.2016.03.006_bib0400","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1017\/S0031182000063241","article-title":"Low-dose oral administration of human interferon alpha can control the development of Theileria parva infection in cattle","volume":"101","author":"Young","year":"1990","journal-title":"Parasitology"},{"key":"10.1016\/j.vetimm.2016.03.006_bib0405","unstructured":"de los Santos, T.B., Zhu, J.J., Diaz-San Seguno, F., Grubman, M.J., Koster, M.J., 2012. Antiviral activity of Bovine Type III interferon against foot-and-mouth disease virus. US Patent Application Number 201 201 64171, issued June 28."}],"container-title":["Veterinary Immunology and Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165242716300319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165242716300319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T16:59:28Z","timestamp":1748797168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165242716300319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":81,"alternative-id":["S0165242716300319"],"URL":"https:\/\/doi.org\/10.1016\/j.vetimm.2016.03.006","relation":{},"ISSN":["0165-2427"],"issn-type":[{"value":"0165-2427","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-dose oral interferon modulates expression of inflammatory and autoimmune genes in cattle","name":"articletitle","label":"Article Title"},{"value":"Veterinary Immunology and Immunopathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vetimm.2016.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}